381 related articles for article (PubMed ID: 23452298)
1. A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia.
Dulisse B; Li X; Gayle JA; Barron RL; Ernst FR; Rothman KJ; Legg JC; Kaye JA
J Med Econ; 2013; 16(6):720-35. PubMed ID: 23452298
[TBL] [Abstract][Full Text] [Related]
2. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.
Kuderer NM; Dale DC; Crawford J; Cosler LE; Lyman GH
Cancer; 2006 May; 106(10):2258-66. PubMed ID: 16575919
[TBL] [Abstract][Full Text] [Related]
3. National estimates of the inpatient burden of pediatric bipolar disorder in the United States.
Berry EA; Heaton PT; Kelton CM
J Ment Health Policy Econ; 2011 Sep; 14(3):115-23. PubMed ID: 22116169
[TBL] [Abstract][Full Text] [Related]
4. Resource utilization in patients hospitalized with heart failure: insights from a contemporary national hospital database.
Hauptman PJ; Swindle J; Burroughs TE; Schnitzler MA
Am Heart J; 2008 Jun; 155(6):978-985.e1. PubMed ID: 18513507
[TBL] [Abstract][Full Text] [Related]
5. Cancer chemotherapy treatment patterns and febrile neutropenia in the US Veterans Health Administration.
Wang L; Barron R; Baser O; Langeberg WJ; Dale DC
Value Health; 2014 Sep; 17(6):739-43. PubMed ID: 25236998
[TBL] [Abstract][Full Text] [Related]
6. Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain.
Mayordomo JI; López A; Viñolas N; Castellanos J; Pernas S; Domingo Alonso J; Frau A; Layola M; Antonio Gasquet J; Sánchez J;
Curr Med Res Opin; 2009 Oct; 25(10):2533-42. PubMed ID: 19722781
[TBL] [Abstract][Full Text] [Related]
7. [Clinical burden caused by hospitalization for febrile neutropenia in France in 2010-2011: An analysis of the PMSI database].
Freyer G; Scotte F; Borget I; Bruyas A; Vainchtock A; Chouaid C
Bull Cancer; 2016 Jun; 103(6):552-60. PubMed ID: 27233367
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of pegfilgrastim, filgrastim, and sargramostim prophylaxis for neutropenia-related hospitalization: two US retrospective claims analyses.
Henk HJ; Becker L; Tan H; Yu J; Kavati A; Naeim A; Deeter R; Barron R
J Med Econ; 2013; 16(1):160-8. PubMed ID: 23016568
[TBL] [Abstract][Full Text] [Related]
9. Acute hospital costs after minimally invasive versus open lumbar interbody fusion: data from a US national database with 6106 patients.
Wang MY; Lerner J; Lesko J; McGirt MJ
J Spinal Disord Tech; 2012 Aug; 25(6):324-8. PubMed ID: 21685806
[TBL] [Abstract][Full Text] [Related]
10. Economic burden associated with hospital postadmission dehydration.
Pash E; Parikh N; Hashemi L
JPEN J Parenter Enteral Nutr; 2014 Nov; 38(2 Suppl):58S-64S. PubMed ID: 25233943
[TBL] [Abstract][Full Text] [Related]
11. Cost and mortality associated with hospitalizations in patients with immune thrombocytopenic purpura.
Danese MD; Lindquist K; Gleeson M; Deuson R; Mikhael J
Am J Hematol; 2009 Oct; 84(10):631-5. PubMed ID: 19705429
[TBL] [Abstract][Full Text] [Related]
12. The effect of hospital safety-net burden status on short-term outcomes and cost of care after head and neck cancer surgery.
Genther DJ; Gourin CG
Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1015-22. PubMed ID: 23165375
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of direct medical costs of hospitalization for febrile neutropenia.
Lathia N; Mittmann N; DeAngelis C; Knowles S; Cheung M; Piliotis E; Shear N; Walker S
Cancer; 2010 Feb; 116(3):742-8. PubMed ID: 20029970
[TBL] [Abstract][Full Text] [Related]
14. Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis.
Odetola FO; Gebremariam A; Freed GL
Pediatrics; 2007 Mar; 119(3):487-94. PubMed ID: 17332201
[TBL] [Abstract][Full Text] [Related]
15. Febrile neutropenia-related care and associated costs in elderly patients with breast cancer, lung cancer, or non-Hodgkin lymphoma.
Li S; Liu J; Bowers C; Garawin TAFS; Kim C; Bensink ME; Chandler DB
Support Care Cancer; 2020 Jan; 28(1):113-122. PubMed ID: 30993450
[TBL] [Abstract][Full Text] [Related]
16. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing in-hospital length of stay and mortality in cancer patients suffering from febrile neutropenia.
Lal A; Bhurgri Y; Rizvi N; Virwani M; Memon RU; Saeed W; Sardar MR; Kumar P; Shaikh AJ; Adil S; Masood N; Khurshed M
Asian Pac J Cancer Prev; 2008; 9(2):303-8. PubMed ID: 18712980
[TBL] [Abstract][Full Text] [Related]
18. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
[TBL] [Abstract][Full Text] [Related]
19. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
[TBL] [Abstract][Full Text] [Related]
20. Annual cost of hospitalization, inpatient rehabilitation and sick leave of anal cancer in Germany.
Heitland W; Schädlich PK; Chen X; Rémy V; Moro L
J Med Econ; 2013; 16(3):364-71. PubMed ID: 23253056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]